You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Decadron

Showing 26 - 50 of 533
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (Carfilzomib, Dexamethasone, Isatuximab)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Malignant Brain Tumor, Metastatic Malignant Tumor in the Brain, Recurrent Malignant Brain Tumor Trial in Duarte (Dexamethasone)

Recruiting
  • Malignant Brain Neoplasm
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 3, 2022

Shoulder Arthropathy, Shoulder Pain Trial in Detroit (Celecoxib, Pregabalin, Tramadol)

Recruiting
  • Shoulder Arthropathy
  • Shoulder Pain
  • Detroit, Michigan
    Henry Ford Health
Aug 3, 2022

AML, MDS Trial in Houston (Vibecotamab, Dexamethasone, Acetaminophen)

Recruiting
  • AML
  • MDS
  • Houston, Texas
    M D Anderson Cancer Center
Sep 29, 2022

Plasmacytoma, POEMS Syndrome Trial in Rochester (Dexamethasone, Ixazomib Citrate, Lenalidomide)

Active, not recruiting
  • Plasmacytoma
  • POEMS Syndrome
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 26, 2022

Plasma Cell Myeloma Trial in Atlanta (Belantamab Mafodotin, Dexamethasone, Pomalidomide)

Recruiting
  • Plasma Cell Myeloma
  • Belantamab Mafodotin
  • +2 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Jul 21, 2022

Hematopoietic/Lymphoid Cancer, Richter's Transformation Trial in Houston (Blinatumomab, Dexamethasone)

Completed
  • Hematopoietic/Lymphoid Cancer
  • Richter's Transformation
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2022

Recurrent Plasma Cell Myeloma Trial in Rochester (drug, other, biological)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 19, 2022

Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 2, 2022

Postoperative Pain Trial in Zagazig (Bupivacaine Hydrochloride, Pethidine plus Dexamethasone)

Active, not recruiting
  • Postoperative Pain
  • Bupivacaine Hydrochloride
  • Pethidine plus Dexamethasone
  • Zagazig, Sharkia, Egypt
    Faculty of Medicine , Zagazig University
Mar 31, 2022

Waldenstrom Macroglobulinemia Trial in Boston (Loncastuximab Tesirine, Dexamethasone)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 1, 2022

Diseases of Oesophagus Stomach and Duodenum Trial in Houston (Dexamethasone, Diphenhydramine, Famotidine)

Active, not recruiting
  • Diseases of Oesophagus Stomach and Duodenum
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 7, 2022

Sacro-Iliac Spondylosis Trial in Nashville (Dexamethasone, Triamcinolone Acetonide)

Enrolling by invitation
  • Sacro-Iliac Spondylosis
  • Nashville, Tennessee
    Byron Schneider
Jan 28, 2022

Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 10, 2023

Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

Terminated
Has Results
  • Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 13, 2022

Waldenstrom Macroglobulinemia Trial in Hackensack (Carfilzomib, Rituximab, Dexamethasone)

Completed
Has Results
  • Waldenstrom Macroglobulinemia
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Mar 18, 2022

Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
Mar 24, 2022

Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Ixazomib, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Apr 13, 2022

Plasma Cell Myeloma Trial (Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone)

Not yet recruiting
  • Plasma Cell Myeloma
  • (no location specified)
Dec 22, 2022

Smoldering Multiple Myeloma Trial in Boston (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 15, 2022

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Columbus (procedure, drug, biological)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Biospecimen Collection
  • +9 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 1, 2023

Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 23, 2022

Cholangiocarcinoma, Liver Tumors Trial in Saint Louis (Floxuridine, Dexamethasone, Gemcitabine)

Terminated
  • Cholangiocarcinoma
  • Liver Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 8, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer American Joint Committee

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Aug 1, 2022

Recurrent Plasma Cell Myeloma Trial in United States (Daratumumab, Dexamethasone, Pomalidomide)

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • Daratumumab
  • +2 more
  • Wichita, Kansas
  • +4 more
Jun 13, 2022